Comparison of the Efficacy of Two Brands of Triptorelin (Microrelin and Diphereline) in Reducing Prostate-Specific Antigen and Serum Testosterone in Prostate Cancer: A Double-Blinded Randomized Clinical Trial

BACKGROUND: Gonadotropin-releasing hormone (GnRH) agonists initiate androgen deprivation in treating prostate cancer (PC). Triptorelin is a synthetic GnRH and many of its market brands such as Diphereline have been introduced so far. OBJECTIVES: We compared the efficacy of a sustained-release formul...

Descripción completa

Detalles Bibliográficos
Autores principales: Fazeli, Farid, Nowroozi, Mohammad Reza, Ayati, Mohsen, Latifi, Sahar, Taheri Mahmoodi, Mohsen, Norouzi Javidan, Abbas, Jamshidian, Hassan, Arbab, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537641/
https://www.ncbi.nlm.nih.gov/pubmed/26290848
http://dx.doi.org/10.5812/numonthly.7(3)2015.27107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537641/
https://www.ncbi.nlm.nih.gov/pubmed/26290848
http://dx.doi.org/10.5812/numonthly.7(3)2015.27107

Ejemplares similares